News
Future Fertility adds new partner Apricity Fertility on the heels of achieving UK regulatory approval
Future Fertility received CE Mark approval for its oocyte assessment software in August and continues to steadily grow its presence across Europe

Future Fertility has received UK regulatory approval for its AI-based oocyte assessment software, expanding UK footprint in partnership with Apricity Fertility.
Future Fertility develops AI-powered solutions that empower fertility patients and their providers with personalised insights to help optimise the fertility journey.
The company’s AI decision support software for oocyte (human egg) quality assessment has achieved UK compliance for commercial use across the UK.
Future Fertility previously received CE Mark approval in the summer of 2022. Now, this UK achievement further solidifies their commercial presence in Europe.
Its Oocyte Software is the first and only non-invasive, clinically validated tool to use artificial intelligence to analyse 2D images of oocytes and generate personalised insights about egg quality.
In today’s standard of care, fertility specialists and embryologists make judgments about egg quality based on a patient’s age group, but this doesn’t account for the variability between patients in the same age group, especially among younger patients.
Through VIOLET™ (for egg freezing patients) and MAGENTA™ (for IVF-ICSI patients), patients and providers can understand the likelihood of each retrieved egg developing to a day 5/6 embryo (eligible for blastocyst transfer), which helps to manage expectations for success and optimise treatment plans.
Future Fertility has already teamed up with leading-edge clinics to integrate their AI solutions and provide the best patient care.
As a longstanding collaborator and partner to the CARE Fertility clinic group, the technology has proven to be scientifically valid and useful to the patient experience.
As Future Fertility expands their UK footprint, they are proud to announce a new partnership with their first virtual clinic partner, Apricity.
Apricity is the UK’s first virtual fertility clinic. Their unique virtual model and mobile app has reimagined the fertility journey, enabling patients to easily navigate each step of the fertility process with at-home solutions and access to world class specialists.
Its digital solution is designed to improve the fertility experience and maximise chances of conception via a fully-customised treatment journey for patients.
Apricity partners with a selected network of clinics around the UK to deliver required in-person treatments, bringing visits to a clinic down to two per cycle rather than ten as with a traditional journey.
“The UK is a leading market in fertility care, the birthplace of the first IVF baby,” says Future Fertility CEO, Christy Prada.
“We are proud to have strong partners in the UK and look forward to partnering with Apricity to bring our products to new patient groups and clinics across the region.”
Apricity and Future Fertility’s partnership will launch as a pilot programme, kicking off this year in cooperation with IVF London.
Oocyte assessment will be conducted via the IVF London lab using Future Fertility’s software, and results will be made available to patients to discuss with their fertility specialists.
Apricity CEO, Caroline Noublanche comments: “Apricity are excited to partner with Future Fertility on this pilot, which aligns with our ‘less stress & more success’ approach.
“‘Less stress’ as giving our patients a greater level of transparency on their oocytes and chances right after egg collection and ‘better success’ as complementing Apricity’s own AI and the amazing embryology team at IVF London to make the best informed choices and ultimately improve the chances of conception.”
For more info, visit futurefertility.com.

Fertility
Toxins and climate harms having ‘alarming’ effect on fertility, research warns

Simultaneous exposure to toxic chemicals and climate-related heat may be worsening fertility harms across humans and wildlife, research suggests.
The review of scientific literature looks at how endocrine-disrupting chemicals, often found in plastic, together with climate-related effects such as heat stress, are each linked to lower fertility and fecundity, meaning the ability to reproduce, across species including humans, wildlife and invertebrates.
Though the reproductive harms of each issue in isolation are well studied, there is little research on what happens when living organisms are exposed to both.
“Together, the two issues are likely to pose a greater threat to fertility, and the additive effect is “alarming”, said Susanne Brander, a study lead author and courtesy faculty at Oregon State University.
“You’re not just getting exposed to one, but two, stressors at the same time that both may affect your fertility, and in turn the overall impact is going to be a bit worse,” Brander said.
The paper looked at 177 studies.
Shanna Swan, a co-author on the new paper, co-produced a 2017 study that found sperm levels among men in western countries had fallen by more than 50 per cent over four decades. Other research has suggested human fertility has been declining at a similar rate.
The University of Washington’s Institute for Health Metrics and Evaluation has previously said the world was approaching a “low-fertility future”, with more than three quarters of countries below replacement rate by 2050.
The new paper’s authors focused on the effects of endocrine-disrupting chemicals and substances, including microplastics, bisphenol, phthalates and PFAS.
These are thought to cause a range of serious reproductive problems, disrupt hormones and be a potential driver of falling fertility.
Brander said the harms linked to these chemicals are often similar across organisms, from invertebrates to humans.
Phthalates, for example, have been linked to altered sperm shape in invertebrates, spermatogenesis in rodents, meaning sperm production, and reduced sperm counts in humans.
PFAS are also thought to affect sperm quality, and both have been linked to hormone disruption.
The chemicals are widespread in consumer goods, so people are often regularly exposed.
Meanwhile, previous research has shown how rising temperatures, lower oxygen levels and heat stress, among other effects linked to climate change, may also worsen infertility.
Heat stress has been found to affect human hormones, and is linked to spermatogenesis in rodents and bulls.
Research shows temperature also plays a role in sex determination in fish, reptiles and amphibians.
The species has evolved to choose which sex it produces in part based on temperature, and the heating planet can “push it too far in one direction or the other, which overrides that evolutionary benefit”, Brander said.
Similarly, many endocrine disruptors may alter environmental sex determination.
The study set out some of the overlapping effects of chemical exposure and climate change across taxonomic groups, from invertebrates to humans.
In birds, for example, exposure to increased temperature, PFAS, organochlorines and pyrethroids may each individually cause abnormal sperm, increased fledgling mortality, abnormal testes and population decline.
“What happens if they’re exposed to more than one of those stressors at the same time? There has been little exploration of that question.
“Even if there have not been a lot of studies looking at these simultaneously, if you have two different factors that both cause the same adverse effect, then there’s a likelihood that they are going to be additive,” Brander said.
Katie Pelch, a senior scientist with the Natural Resources Defense Council nonprofit, who was not part of the study, said the authors had reviewed high-quality science.
She said she wanted to see more examples of the overlap in impacts, but agreed with the overall premise.
“It is likely [multiple stressors] would have an additive effect, at very least, even if they have different mechanisms of harm,” Pelch added.
The solution to the systemic problems would involve tackling climate change and reducing the use of toxic chemicals.
The study cites the global reduction in the use of DDT and PCBs achieved under the Stockholm Convention as an example of an effective measure, but Brander said much more is needed.
“There is enough evidence in both areas to act to reduce our impact on the planet,” she said.
Diagnosis
Home blood pressure checks could lower heart risks for new mothers – study
Fertility
Researcher explores weight loss jab impact on PCOS
Entrepreneur4 weeks agoThree sessions that show exactly where women’s health is heading in 2026
Entrepreneur4 days agoFuture Fertility raises Series A financing to scale AI tools redefining fertility care worldwide
Pregnancy4 weeks agoHow NIPT has evolved and what AI NIPT means in 2026
News4 weeks agoTwo weeks left to make your mark in women’s cardiovascular health
Opinion4 weeks agoQ1 momentum: Female founders are advancing, but the system still hasn’t caught up
Diagnosis2 weeks agoFuture Fertility partners with Japan’s leading IVF provider, Kato Ladies Clinic
Mental health6 days agoLifting weights shows mental health and cognitive benefits in older women, study finds
Menopause2 weeks agoMore research needed to understand link between brain fog and menopause, expert says














